Back
Corporate News
Senores Pharmaceuticals appoints Dr. Shah as Director and approves ESOS 2026 for employees
26-Aug-2026, 08:40
Senores Pharmaceuticals Limited announced the appointment of Dr. Viranchi Arvindbhai Shah as a Director, bringing extensive experience in pharmaceuticals, policy, and international trade. The company also secured approval for the Senores Pharmaceuticals Employee Stock Option Scheme 2026 (ESOS 2026), granting 4,72,000 options to eligible employees, representing 1% of existing equity, with a potential discount of up to 50% on the market price. Furthermore, Senores Pharmaceuticals plans to incorporate a wholly-owned subsidiary in Mexico for pharmaceutical supply and distribution, and a subsidiary in Canada with at least 51% ownership, both requiring regulatory approvals and involving cash consideration.